Literature DB >> 15026844

EuCliD--a medical registry.

H Steil1, C Amato, C Carioni, J Kirchgessner, D Marcelli, A Mitteregger, V Moscardo, G Orlandini, E Gatti.   

Abstract

OBJECTIVES: The European Clinical Database EuCliD small star, filled has been developed as a tool for supervising selected quality indicators of about 200 European dialysis centers. Major efforts had to be made to comply with local and European laws regarding data security.
METHOD: EuCliD is a Lotus Notes based flat-file database currently containing medical data of more than 14,000 dialysis patients from 10 European countries. Another 15,000 patients from 150 centers in 4 South-American countries will be added soon. Data are entered either manually or by means of interfaces to existing local data managing systems. This information is transferred to a central Lotus Notes Server. Data evaluation was performed with statistical tools like SPSS.
RESULTS: EuCliD is used as a part of the CQI (Continuous Quality Improvement) management system of Fresenius Medical Care (FMC) dialysis units. Each participating dialysis center receives (currently every half year) benchmarking reports at a regular interval. The benchmark for all quality parameters is the weighted mean of the corresponding data of all centers.
CONCLUSIONS: An obvious impact of data sampling and data evaluation on the quality of the treatments could be observed within the first one and a half years of working with EuCliD. This also concerns important outcome predictors like Kt/V and hemoglobin concentration as the outcome itself expressed in hospitalization days and survival rates. With the help of EuCliD the user is able to sample clinical data, identify problems, search for solutions with the aim of improving the dialysis treatment quality and guarantee a high-class treatment quality for all patients.

Entities:  

Mesh:

Year:  2004        PMID: 15026844

Source DB:  PubMed          Journal:  Methods Inf Med        ISSN: 0026-1270            Impact factor:   2.176


  11 in total

1.  Use of Self-Organizing Maps for Balanced Scorecard analysis to monitor the performance of dialysis clinic chains.

Authors:  Isabella Cattinelli; Elena Bolzoni; Carlo Barbieri; Flavio Mari; José David Martin-Guerrero; Emilio Soria-Olivas; José Maria Martinez-Martinez; Juan Gomez-Sanchis; Claudia Amato; Andrea Stopper; Emanuele Gatti
Journal:  Health Care Manag Sci       Date:  2011-11-15

2.  Achieving the goal of the Fistula First breakthrough initiative for prevalent maintenance hemodialysis patients.

Authors:  Janet R Lynch; Haimanot Wasse; Nancy C Armistead; William M McClellan
Journal:  Am J Kidney Dis       Date:  2010-11-30       Impact factor: 8.860

3.  Inflammation Modifies the Paradoxical Association between Body Mass Index and Mortality in Hemodialysis Patients.

Authors:  Peter Stenvinkel; Iain A Gillespie; Jamie Tunks; Janet Addison; Florian Kronenberg; Tilman B Drueke; Daniele Marcelli; Guntram Schernthaner; Kai-Uwe Eckardt; Jürgen Floege; Marc Froissart; Stefan D Anker
Journal:  J Am Soc Nephrol       Date:  2015-11-13       Impact factor: 10.121

4.  Propensity score matching and persistence correction to reduce bias in comparative effectiveness: the effect of cinacalcet use on all-cause mortality.

Authors:  Iain A Gillespie; Jürgen Floege; Ioanna Gioni; Tilman B Drüeke; Angel L de Francisco; Stefan D Anker; Yumi Kubo; David C Wheeler; Marc Froissart
Journal:  Pharmacoepidemiol Drug Saf       Date:  2015-05-26       Impact factor: 2.890

5.  Haemodialysis therapy and sustainable growth: a corporate experience in France.

Authors:  Georges Bendine; Fabien Autin; Bruno Fabre; Olivier Bardin; François Rabasco; Jean-Marc Cabanel; Charles Chazot
Journal:  Nephrol Dial Transplant       Date:  2020-12-04       Impact factor: 5.992

6.  Impact of mineral and bone disorder on healthcare resource use and associated costs in the European Fresenius medical care dialysis population: a retrospective cohort study.

Authors:  Silvia Chiroli; Caroline Mattin; Vasily Belozeroff; Louise Perrault; Dominic Mitchell; Ioanna Gioni
Journal:  BMC Nephrol       Date:  2012-10-29       Impact factor: 2.388

7.  Proton Pump Inhibitor Usage and the Risk of Mortality in Hemodialysis Patients.

Authors:  Angel L M de Francisco; Javier Varas; Rosa Ramos; Jose Ignacio Merello; Bernard Canaud; Stefano Stuard; Julio Pascual; Pedro Aljama
Journal:  Kidney Int Rep       Date:  2017-11-10

8.  Hospitalization and mortality following non-attendance for hemodialysis according to dialysis day of the week: a European cohort study.

Authors:  James Fotheringham; Michael T Smith; Marc Froissart; Florian Kronenberg; Peter Stenvinkel; Jürgen Floege; Kai-Uwe Eckardt; David C Wheeler
Journal:  BMC Nephrol       Date:  2020-06-09       Impact factor: 2.388

9.  Is high-volume post-dilution haemodiafiltration associated with risk of fluid volume imbalance? A national multicentre cross-sectional cohort study.

Authors:  Charles Chazot; Sebastien Deleuze; Baya Fadel; Hadia Hebibi; Guillaume Jean; Martial Levannier; Olivier Puyoo; David Attaf; Stefano Stuard; Bernard Canaud
Journal:  Nephrol Dial Transplant       Date:  2019-12-01       Impact factor: 5.992

10.  Survival on four compared with three times per week haemodialysis in high ultrafiltration patients: an observational study.

Authors:  James Fotheringham; Nicholas Latimer; Marc Froissart; Florian Kronenberg; Peter Stenvinkel; Jürgen Floege; Kai-Uwe Eckardt; David C Wheeler
Journal:  Clin Kidney J       Date:  2020-12-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.